These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 5923168)

  • 1. The binding of beta-propiolactone to mouse skin DNA in vivo; its correlation with tumor-initiating activity.
    Colburn NH; Boutwell RK
    Cancer Res; 1966 Aug; 26(8):1701-6. PubMed ID: 5923168
    [No Abstract]   [Full Text] [Related]  

  • 2. The binding of beta-propiolactone and some related alkylating agents to DNA, RNA, and protein of mouse skin; relation between tumor-initiating power of alkylating agents and their binding to DNA.
    Colburn NH; Boutwell RK
    Cancer Res; 1968 Apr; 28(4):653-60. PubMed ID: 5649056
    [No Abstract]   [Full Text] [Related]  

  • 3. The in vivo binding of beta-propiolactone to mouse skin DNA, RNA, and protein.
    Colburn NH; Boutwell RK
    Cancer Res; 1968 Apr; 28(4):642-52. PubMed ID: 5649055
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition by actinomycin D of DNA and RNA synthesis and of skin carcinogenesis initiated by 7,12-dimethylbenz[a]anthracene or beta-propiolactone.
    Hennings H; Smith HC; Colburn NH; Boutwell RK
    Cancer Res; 1968 Mar; 28(3):543-52. PubMed ID: 5640870
    [No Abstract]   [Full Text] [Related]  

  • 5. The inhibition of DNA synthesis by initiators of mouse skin tumorigenesis.
    Hennings H; Boutwell RK
    Cancer Res; 1969 Mar; 29(3):510-4. PubMed ID: 5773798
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of hydroxyurea on DNA and RNA synthesis in mouse skin, liver, and thymus and on skin tumorigenesis initiated by beta-propiolactone.
    Smith HC; Boutwell RK; Potter VR
    Cancer Res; 1968 Nov; 28(11):2217-27. PubMed ID: 5723966
    [No Abstract]   [Full Text] [Related]  

  • 7. Skin irritation and skin tumor production by beta propiolactone (BPL).
    PALMES ED; ORRIS L; NELSON N
    Am Ind Hyg Assoc J; 1962; 23():257-64. PubMed ID: 14483427
    [No Abstract]   [Full Text] [Related]  

  • 8. Benzo(a)pyrene-DNA adduct formation and removal in mouse epidermis in vivo and in vitro: relationship of DNA binding to initiation of skin carcinogenesis.
    Nakayama J; Yuspa SH; Poirier MC
    Cancer Res; 1984 Sep; 44(9):4087-95. PubMed ID: 6331664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies of the effects in vitro of beta-propiolactone and beta-propiolact(14C)one on whole mouse skin chromatin.
    Segal A; Schroeder M; Barnett P; Van Duuren BL
    Biochem Pharmacol; 1974 Mar; 23(5):937-46. PubMed ID: 4458678
    [No Abstract]   [Full Text] [Related]  

  • 10. Formation and persistence of DNA, RNA, and protein adducts in mouse skin exposed to pure optical enantiomers of 7 beta,8 alpha-dihydroxy-9 alpha,10 alpha-epoxy-7,8,9,10-tetrahydrobenzo(a)pyre ne in vivo.
    Pelling JC; Slaga TJ; DiGiovanni J
    Cancer Res; 1984 Mar; 44(3):1081-6. PubMed ID: 6198079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of beta-propiolactone and neighboring derivatives on the in vitro synthesis of DNA or RNA].
    Moreau J; Daudel P
    Bull Cancer; 1972; 59(3):331-8. PubMed ID: 4667742
    [No Abstract]   [Full Text] [Related]  

  • 12. Demonstration of in vivo DNA repair synthesis in mouse skin exposed to various chemical carcinogens.
    Ishikawa T; Kodama K; Ide F; Takayama S
    Cancer Res; 1982 Dec; 42(12):5216-21. PubMed ID: 7139625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumorigenic activity of benzo(e)pyrene derivatives on mouse skin and in newborn mice.
    Buening MK; Levin W; Wood AW; Chang RL; Lehr RE; Taylor CW; Yagi H; Jerina DM; Conney AH
    Cancer Res; 1980 Feb; 40(2):203-6. PubMed ID: 7356502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of 7-bromomethylbenz[a]anthracene-promoted mouse skin tumor formation by retinoic acid and dexamethasone.
    Verma AK; Garcia CT; Ashendel CL; Boutwell RK
    Cancer Res; 1983 Jul; 43(7):3045-9. PubMed ID: 6406052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exceptionally high tumor-initiating activity of benzo(c)phenanthrene bay-region diol-epoxides on mouse skin.
    Levin W; Wood AW; Chang RL; Ittah Y; Croisy-Delcey M; Yagi H; Jerina DM; Conney AH
    Cancer Res; 1980 Nov; 40(11):3910-4. PubMed ID: 7471042
    [No Abstract]   [Full Text] [Related]  

  • 16. Targeted expression of human O(6)-methylguanine-DNA methyltransferase (MGMT) in transgenic mice protects against tumor initiation in two-stage skin carcinogenesis.
    Becker K; Dosch J; Gregel CM; Martin BA; Kaina B
    Cancer Res; 1996 Jul; 56(14):3244-9. PubMed ID: 8764116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Teleocidin: new naturally occurring tumor promoter.
    Sugimura T; Fujiki H; Mori M; Nakayasu M; Terada M; Umezawa K; Moore RE
    Carcinog Compr Surv; 1982; 7():69-73. PubMed ID: 6802497
    [No Abstract]   [Full Text] [Related]  

  • 18. Modulation of oxidant formation in mouse skin in vivo by tumor-promoting phorbol esters.
    Marnett LJ; Ji C
    Cancer Res; 1994 Apr; 54(7 Suppl):1886s-1889s. PubMed ID: 8137305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of skin tumorigenesis by rosemary and its constituents carnosol and ursolic acid.
    Huang MT; Ho CT; Wang ZY; Ferraro T; Lou YR; Stauber K; Ma W; Georgiadis C; Laskin JD; Conney AH
    Cancer Res; 1994 Feb; 54(3):701-8. PubMed ID: 8306331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circadian variation in the susceptibility of mouse epidermis to chemical carcinogens.
    Iversen OH; Kauffman SL
    Int J Chronobiol; 1981; 8(1):49-62. PubMed ID: 7341497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.